Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2025-12-27 @ 9:54 PM
Study NCT ID:
NCT06250959
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
Sponsor:
Organization: